My Take on the 2023 CDC Annual Review of the Childhood and Adult Schedules
Is the CDC's rapidly expanding vaccine schedule empowering healthcare institutions at the cost of parental consent and individual health sovereignty?
“We’re going to need a bigger refrigerator for all the vaccines.”
Dr. Grace Lee, Chair of the CDC Advisory Committee on Immunization Practices (ACIP)
Meeting Summary:
The CDC's Advisory Committee on Immunization Practices (ACIP) met on Oct. 25 and 26 to review the adult and childhood vaccination schedules, highlighting its rapid expansion. Link to slides from the meeting here. I summarized the key points originally published by Stand for Health Freedom below:
Addition of nirsevimab, a monoclonal antibody aimed at preventing RSV in infants, expands the definition of immunizing agents.
Mpox, an unlicensed vaccine for children (under the pretense of a 2022 EUA), was added for at-risk adolescents at 18, with potential for children to receive it without parental consent.
Adult vaccination schedules are also expanding, with calls for a financing program similar to the Vaccines for Children program.
New RSV vaccines for pregnant mothers were added but are not yet covered by the Vaccine Injury Compensation Program.
Expect changing recommendations for meningitis vaccines as Pfizer’s new “pentavalent” vaccine was licensed.
Manufacturers have flexibility to update the schedule, which could affect vaccine commercialization.
The government sees itself as more effective than the private sector in vaccine distribution.
Rapid recommendations by ACIP post FDA-approvals have been criticized for diminishing individualized care.
Countermeasures Injury Compensation claims for COVID-19 vaccines have reached over 12,000.
As pregnancy vaccine recommendations increase, uptake decreases.
Government surveys suggest low uptake for the new 2023-2024 COVID-19 vaccine, although data may be skewed.
The low vaccination rates for the latest COVID-19 vaccine were noted, sparking a call for increased health advocacy. Despite challenges, they expressed optimism for more informed vaccine choices.
My take:
From the perspective of The Deindustrialist, the recent meeting of the CDC’s Advisory Committee on Immunization Practices (ACIP) reveals some disconcerting trends that resonate with our core mission to empower families and question the industrial healthcare machine.
Expanded Definition of Immunizing Agents: The inclusion of a monoclonal antibody like nirsevimab not only muddies the water around what constitutes a vaccine but also reflects an unwelcome expansion of substances that might be administered without clear parental oversight.
Unlicensed Vaccines in the Schedule: The addition of Mpox, the second unlicensed vaccine now in the schedule, raises red flags about the sanctity of parental consent and hints at a growing detachment from grassroots medical decision-making.
Financing Programs: The push for an adult equivalent to the Vaccines for Children program suggests the state seeks further entanglement in personal health choices, contrary to our mission of individual and family sovereignty.
Vaccine Injury Compensation: The lack of coverage for new RSV vaccines within the Vaccine Injury Compensation Program means that the families who experience adverse effects are left without redress, exacerbating the power imbalance between them and the healthcare industry.
Changing Recommendations: The mutating recommendations for meningitis vaccines demonstrate that the vaccination schedule is less a stable protocol for wellness than a shifting ground of corporate influence.
Blank Check for Manufacturers: The open-ended nature of vaccine schedule updates gives an alarming amount of power to pharmaceutical companies, rather than placing trust in families and their doctors to make informed decisions about their own health.
Commercialization vs. Public Health: The government's belief in their superior ability to administer vaccines challenges our belief in the free market and individual choice as the best arbiters of public well-being.
Rapid Recommendations and Individualized Care: The push for speedy approval and recommendation, driven by the 21st Century Cures Act, undercuts the practice of individualized and thoughtful medicine, reducing it to mere compliance with federal guidelines.
Injury Compensation for COVID-19 Vaccines: The rising number of claims is a clarion call to scrutinize the long-term effects and trade-offs involved in mass immunization programs.
Decreasing Uptake in Pregnancy: The decline in vaccine acceptance among pregnant women indicates a growing public distrust in official health narratives, reinforcing the need for transparent, community-based dialogues around vaccination. Both vaccines AND trust in vaccines are necessary when it comes to protecting the health of our children
Low Uptake of New COVID-19 Vaccine: This could be an encouraging sign that people are increasingly questioning top-down health mandates and seeking more transparent information before making medical decisions.
The ACIP's growing influence and the rapid expansion of the vaccine schedule highlight the escalating tension between individual freedom and institutional oversight in healthcare. These developments underscore the urgency of our work at The Deindustrialist to equip families with the knowledge and tools they need to reclaim their health sovereignty from corporate and governmental influences.
I hope everyone has a great start to their week, and as always:
Stay Informed. Stay Empowered. Stay Free.
-Greg